Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Certain drugs change freshwater snail shells to a "banana" shape.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.